Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ACUTE MYELOID LEUKEMIA; AML”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01907815
What this trial is testing

Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Recurrent Adult Acute Myeloid LeukemiaUntreated Adult Acute Myeloid Leukemia
National Cancer Institute (NCI) 24
Not applicableStudy completedNCT00919425
What this trial is testing

S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
SWOG Cancer Research Network 1,294
Testing effectiveness (Phase 2)Ended earlyNCT05886491
What this trial is testing

GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Leukemia
Takeda 16
Testing effectiveness (Phase 2)Study completedNCT01702155
What this trial is testing

Phase I/II Study of DFP-10917 in Patients With Acute Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic Leukemia
Delta-Fly Pharma, Inc. 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT04980885
What this trial is testing

A Trial of AK117 (Anti-CD47 Antibody) in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Akeso 68
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07507825
What this trial is testing

Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)

Who this might be right for
Acute Myeloid Leukemia (AML)
First People's Hospital of Hangzhou 61
Testing effectiveness (Phase 2)Study completedNCT03338348
What this trial is testing

Study of Vosaroxin With Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome With Excess Blasts-2 (MDS-EB-2)
University of Ulm 9
Not applicableStudy completedNCT01575535
What this trial is testing

S0106B Studying Bone Marrow Samples From Women With Acute Myeloid Leukemia

Who this might be right for
Leukemia
SWOG Cancer Research Network 100
Early research (Phase 1)Study completedNCT03127735
What this trial is testing

BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia, Myeloid, Acute
Bayer 27
Very early researchUnknownNCT05574608
What this trial is testing

Allogenic CD123-CAR-NK Cells in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia RefractoryAcute Myeloid Leukemia Recurrent
Affiliated Hospital to Academy of Military Medical Sciences 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06783478
What this trial is testing

NK Cell Infusion for Remission Consolidation in AML: A Phase II Trial

Who this might be right for
Acute Myeloid Leukaemia (AML)
Hospital de Clinicas de Porto Alegre 98
Not applicableStudy completedNCT00554489
What this trial is testing

Physical Activity in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy

Who this might be right for
Leukemia
Wake Forest University Health Sciences 26
Testing effectiveness (Phase 2)WithdrawnNCT04354025
What this trial is testing

Cytokine-induced Memory-like NK Cells in Combination With Chemotherapy in Pediatric Patents With Refractory or Relapsed AML

Who this might be right for
Refractory Acute Myeloid LeukemiaRelapsed Acute Myeloid Leukemia
Washington University School of Medicine
Testing effectiveness (Phase 2)Ended earlyNCT03071276
What this trial is testing

Selinexor in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
St. Jude Children's Research Hospital 37
Testing effectiveness (Phase 2)Looking for participantsNCT06928376
What this trial is testing

RCT of "3+7" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients

Who this might be right for
Acute Myeloid LeukemiaFirst Line Therapy
Chinese PLA General Hospital 160
Testing effectiveness (Phase 2)Study completedNCT00025545
What this trial is testing

Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia</p>

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01349972
What this trial is testing

Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+13 more
National Cancer Institute (NCI) 172
Not applicableUnknownNCT02192619
What this trial is testing

National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup

Who this might be right for
Newly-diagnosed APL (de Novo or Therapy-related)Relapsed APL
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 500
Early research (Phase 1)Study completedNCT00077467
What this trial is testing

Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia

Who this might be right for
Blastic Phase Chronic Myelogenous LeukemiaChildhood Acute Promyelocytic Leukemia (M3)Recurrent Childhood Acute Lymphoblastic Leukemia+1 more
National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT00004009
What this trial is testing

R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
University of Maryland, Baltimore
Next Page